160 related articles for article (PubMed ID: 10617275)
1. High levels of BCL-2 messenger RNA detected by in situ hybridization in human hepatocellular and cholangiocellular carcinomas.
Fiorentino M; D'Errico A; Altimari A; Barozzi C; Grigioni WF
Diagn Mol Pathol; 1999 Dec; 8(4):189-94. PubMed ID: 10617275
[TBL] [Abstract][Full Text] [Related]
2. Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection.
D'Errico A; Baccarini P; Fiorentino M; Ceccarelli C; Bonazzi C; Ponzetto A; Scoazec JY; Mancini AM; Grigioni WF
Hum Pathol; 1996 Jun; 27(6):599-604. PubMed ID: 8666372
[TBL] [Abstract][Full Text] [Related]
3. Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.
Tickoo SK; Zee SY; Obiekwe S; Xiao H; Koea J; Robiou C; Blumgart LH; Jarnagin W; Ladanyi M; Klimstra DS
Am J Surg Pathol; 2002 Aug; 26(8):989-97. PubMed ID: 12170085
[TBL] [Abstract][Full Text] [Related]
4. Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigens (bcl-2, c-myc, Fas, Lewis(y) and p53) in human cholangiocarcinomas and hepatocellular carcinomas.
Terada T; Nakanuma Y
Pathol Int; 1996 Oct; 46(10):764-70. PubMed ID: 8916146
[TBL] [Abstract][Full Text] [Related]
5. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z
Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
[TBL] [Abstract][Full Text] [Related]
6. MiR-126 in Hepatocellular Carcinoma and Cholangiocellular Carcinoma: A Reappraisal with an
Zailaie SA; Sergi CM
Ann Clin Lab Sci; 2022 Jan; 52(1):73-85. PubMed ID: 35181620
[TBL] [Abstract][Full Text] [Related]
7. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma.
Thasler WE; Schlott T; Thelen P; Hellerbrand C; Bataille F; Lichtenauer M; Schlitt HJ; Jauch KW; Weiss TS
Histopathology; 2005 Jul; 47(1):57-66. PubMed ID: 15982324
[TBL] [Abstract][Full Text] [Related]
8. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.
Shirakawa H; Kuronuma T; Nishimura Y; Hasebe T; Nakano M; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kobayashi N; Kinoshita T; Nakatsura T
Int J Oncol; 2009 Mar; 34(3):649-56. PubMed ID: 19212669
[TBL] [Abstract][Full Text] [Related]
9. Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma.
Itoyama M; Hata M; Yamanegi K; Yamada N; Ohyama H; Hirano H; Terada N; Nakasho K
Med Mol Morphol; 2012 Dec; 45(1):7-13. PubMed ID: 22431178
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.
Wu F; Nishioka M; Fujita J; Murota M; Ohtsuki Y; Ishida T; Kuriyama S
Int J Oncol; 2002 Jan; 20(1):31-7. PubMed ID: 11743639
[TBL] [Abstract][Full Text] [Related]
11. Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse Sites.
Nasir A; Lehrke HD; Mounajjed T; Said S; Zhang L; Yasir S; Shah SS; Chandan VS; Smyrk TC; Moreira RK; Boland Froemming JM; Herrera Hernandez LP; Wu TT; Graham RP
Am J Clin Pathol; 2019 Jul; 152(2):190-199. PubMed ID: 31107526
[TBL] [Abstract][Full Text] [Related]
12. The potential role of bcl-2 mRNA and protein exression in hepatocellular carcinomas.
Ravazoula P; Tsamandas AC; Kardamakis D; Gogos C; Karatza C; Thomopoulos K; Tepetes K; Kourelis T; Petsas T; Bonikos DS; Karavias D
Anticancer Res; 2002; 22(3):1799-805. PubMed ID: 12168872
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.
Zimmerman RL; Fogt F; Burke M; Murakata LA
Oncol Rep; 2002; 9(4):689-92. PubMed ID: 12066193
[TBL] [Abstract][Full Text] [Related]
14. Genetics of hepatobiliary carcinogenesis.
Nault JC; Zucman-Rossi J
Semin Liver Dis; 2011 May; 31(2):173-87. PubMed ID: 21538283
[TBL] [Abstract][Full Text] [Related]
15. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
Maeda T; Kajiyama K; Adachi E; Takenaka K; Sugimachi K; Tsuneyoshi M
Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
Stroescu C; Herlea V; Dragnea A; Popescu I
J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
[TBL] [Abstract][Full Text] [Related]
17. Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):737-48. PubMed ID: 23573322
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma.
Tannapfel A; Sommerer F; Benicke M; Katalinic A; Uhlmann D; Witzigmann H; Hauss J; Wittekind C
Gut; 2003 May; 52(5):706-12. PubMed ID: 12692057
[TBL] [Abstract][Full Text] [Related]
19. Annexin A1: A new immunohistological marker of cholangiocarcinoma.
Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S
World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846
[TBL] [Abstract][Full Text] [Related]
20. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.
Morcos M; Dubois S; Bralet MP; Belghiti J; Degott C; Terris B
Am J Clin Pathol; 2001 Nov; 116(5):738-43. PubMed ID: 11710692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
